Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thoracic Injuries | 4 | 2021 | 44 | 1.040 |
Why?
|
Wounds and Injuries | 3 | 2022 | 334 | 0.910 |
Why?
|
Elevators and Escalators | 1 | 2021 | 2 | 0.810 |
Why?
|
Accidental Falls | 1 | 2022 | 84 | 0.760 |
Why?
|
Emergency Service, Hospital | 3 | 2022 | 711 | 0.700 |
Why?
|
Wounds, Nonpenetrating | 4 | 2022 | 131 | 0.590 |
Why?
|
Hospitalization | 2 | 2022 | 978 | 0.520 |
Why?
|
Retrospective Studies | 11 | 2022 | 7277 | 0.340 |
Why?
|
Craniocerebral Trauma | 2 | 2021 | 50 | 0.320 |
Why?
|
Electroporation | 2 | 2018 | 11 | 0.300 |
Why?
|
Soft Tissue Neoplasms | 2 | 2018 | 28 | 0.300 |
Why?
|
Logistic Models | 3 | 2021 | 1420 | 0.300 |
Why?
|
Age Factors | 3 | 2021 | 1864 | 0.270 |
Why?
|
Adult | 14 | 2022 | 21403 | 0.250 |
Why?
|
Tomography, X-Ray Computed | 7 | 2022 | 2324 | 0.240 |
Why?
|
Humans | 27 | 2022 | 68618 | 0.240 |
Why?
|
Hemorrhage | 3 | 2022 | 328 | 0.230 |
Why?
|
Hemostatics | 1 | 2022 | 47 | 0.200 |
Why?
|
Facial Injuries | 1 | 2021 | 10 | 0.200 |
Why?
|
Neck Injuries | 1 | 2021 | 17 | 0.200 |
Why?
|
Traumatology | 1 | 2021 | 20 | 0.200 |
Why?
|
Resuscitation | 2 | 2022 | 77 | 0.200 |
Why?
|
Intracranial Pressure | 1 | 2021 | 58 | 0.200 |
Why?
|
Heart Arrest | 1 | 2022 | 113 | 0.190 |
Why?
|
Seasons | 1 | 2021 | 129 | 0.190 |
Why?
|
Venous Thrombosis | 1 | 2022 | 125 | 0.190 |
Why?
|
Sex Distribution | 1 | 2021 | 274 | 0.190 |
Why?
|
Prosthesis Implantation | 1 | 2021 | 83 | 0.190 |
Why?
|
Hidradenitis Suppurativa | 1 | 2020 | 6 | 0.180 |
Why?
|
Male | 15 | 2021 | 37321 | 0.180 |
Why?
|
Surgeons | 1 | 2021 | 68 | 0.180 |
Why?
|
Appendiceal Neoplasms | 1 | 2020 | 9 | 0.180 |
Why?
|
Carcinoid Tumor | 1 | 2020 | 20 | 0.180 |
Why?
|
Automobiles | 1 | 2020 | 26 | 0.180 |
Why?
|
Pelvic Bones | 1 | 2020 | 7 | 0.180 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 219 | 0.180 |
Why?
|
Skin Transplantation | 1 | 2020 | 45 | 0.180 |
Why?
|
Embolization, Therapeutic | 1 | 2022 | 150 | 0.180 |
Why?
|
Hemostatic Techniques | 1 | 2020 | 23 | 0.180 |
Why?
|
Chi-Square Distribution | 1 | 2021 | 546 | 0.180 |
Why?
|
Appendectomy | 1 | 2020 | 47 | 0.180 |
Why?
|
Emergencies | 1 | 2020 | 107 | 0.180 |
Why?
|
Colectomy | 1 | 2020 | 64 | 0.180 |
Why?
|
Brain Injuries, Traumatic | 1 | 2021 | 105 | 0.180 |
Why?
|
Diphenoxylate | 1 | 2019 | 1 | 0.170 |
Why?
|
Loperamide | 1 | 2019 | 2 | 0.170 |
Why?
|
Metoclopramide | 1 | 2019 | 21 | 0.170 |
Why?
|
Ileus | 1 | 2019 | 7 | 0.170 |
Why?
|
Erythromycin | 1 | 2019 | 13 | 0.170 |
Why?
|
Diet Therapy | 1 | 2019 | 22 | 0.170 |
Why?
|
Diarrhea | 1 | 2019 | 63 | 0.170 |
Why?
|
Acute Kidney Injury | 1 | 2022 | 232 | 0.170 |
Why?
|
Fractures, Bone | 1 | 2020 | 132 | 0.170 |
Why?
|
Injury Severity Score | 4 | 2022 | 204 | 0.170 |
Why?
|
Burns | 1 | 2020 | 83 | 0.170 |
Why?
|
Adolescent | 2 | 2022 | 8912 | 0.170 |
Why?
|
Giant Cell Tumors | 1 | 2018 | 1 | 0.160 |
Why?
|
Hernia | 1 | 2018 | 13 | 0.160 |
Why?
|
Middle Aged | 10 | 2021 | 21147 | 0.160 |
Why?
|
Female | 12 | 2021 | 38074 | 0.160 |
Why?
|
Accidents, Traffic | 2 | 2018 | 109 | 0.160 |
Why?
|
Fasciitis, Necrotizing | 1 | 2018 | 15 | 0.160 |
Why?
|
Ablation Techniques | 1 | 2018 | 33 | 0.160 |
Why?
|
Herniorrhaphy | 1 | 2018 | 38 | 0.160 |
Why?
|
Debridement | 1 | 2018 | 55 | 0.160 |
Why?
|
Soft Tissue Infections | 1 | 2018 | 19 | 0.160 |
Why?
|
Sarcoma | 1 | 2018 | 70 | 0.160 |
Why?
|
Water Sports | 1 | 2017 | 2 | 0.150 |
Why?
|
Peritoneal Lavage | 1 | 2017 | 5 | 0.150 |
Why?
|
Intra-Abdominal Hypertension | 1 | 2017 | 1 | 0.150 |
Why?
|
Enteral Nutrition | 1 | 2019 | 157 | 0.150 |
Why?
|
Critical Illness | 1 | 2019 | 191 | 0.150 |
Why?
|
Trauma Centers | 1 | 2019 | 197 | 0.150 |
Why?
|
Ileal Diseases | 1 | 2017 | 8 | 0.150 |
Why?
|
Opioid-Related Disorders | 1 | 2022 | 298 | 0.150 |
Why?
|
Intussusception | 1 | 2017 | 16 | 0.150 |
Why?
|
Shock, Hemorrhagic | 1 | 2017 | 33 | 0.150 |
Why?
|
Diseases in Twins | 1 | 2017 | 31 | 0.150 |
Why?
|
Incidence | 1 | 2021 | 1603 | 0.150 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 84 | 0.150 |
Why?
|
Abdominal Injuries | 1 | 2017 | 60 | 0.150 |
Why?
|
Athletic Injuries | 1 | 2017 | 73 | 0.140 |
Why?
|
Lung Diseases | 1 | 2018 | 175 | 0.140 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 13 | 0.140 |
Why?
|
Splenic Rupture | 1 | 2016 | 5 | 0.140 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2016 | 12 | 0.140 |
Why?
|
Palliative Care | 1 | 2019 | 271 | 0.140 |
Why?
|
Guideline Adherence | 1 | 2019 | 287 | 0.140 |
Why?
|
Leg Injuries | 1 | 2016 | 18 | 0.140 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 498 | 0.140 |
Why?
|
Pancreas | 1 | 2017 | 225 | 0.140 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 438 | 0.130 |
Why?
|
Wounds, Gunshot | 1 | 2016 | 48 | 0.130 |
Why?
|
Hypopituitarism | 1 | 2015 | 5 | 0.130 |
Why?
|
Adrenal Insufficiency | 1 | 2015 | 10 | 0.130 |
Why?
|
Pancreatitis | 1 | 2017 | 279 | 0.130 |
Why?
|
Multiple Trauma | 1 | 2015 | 50 | 0.130 |
Why?
|
Postoperative Complications | 2 | 2019 | 1615 | 0.120 |
Why?
|
Aged | 5 | 2021 | 14862 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 786 | 0.110 |
Why?
|
Length of Stay | 1 | 2017 | 780 | 0.110 |
Why?
|
Sex Factors | 1 | 2017 | 1266 | 0.110 |
Why?
|
Obesity | 1 | 2020 | 1076 | 0.110 |
Why?
|
Young Adult | 2 | 2021 | 5717 | 0.110 |
Why?
|
Treatment Outcome | 6 | 2021 | 7029 | 0.110 |
Why?
|
Mitochondria | 1 | 2017 | 643 | 0.110 |
Why?
|
Gastrointestinal Motility | 2 | 2019 | 52 | 0.080 |
Why?
|
Peritoneum | 2 | 2020 | 27 | 0.080 |
Why?
|
Time-to-Treatment | 2 | 2021 | 117 | 0.080 |
Why?
|
United States | 2 | 2019 | 7367 | 0.080 |
Why?
|
Aged, 80 and over | 1 | 2017 | 4848 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 931 | 0.060 |
Why?
|
Acute Disease | 2 | 2017 | 658 | 0.060 |
Why?
|
Prospective Studies | 2 | 2022 | 3705 | 0.050 |
Why?
|
Thoracotomy | 1 | 2022 | 25 | 0.050 |
Why?
|
Historically Controlled Study | 1 | 2021 | 7 | 0.050 |
Why?
|
APACHE | 1 | 2021 | 41 | 0.050 |
Why?
|
Glasgow Coma Scale | 1 | 2021 | 65 | 0.050 |
Why?
|
Narcotics | 1 | 2022 | 65 | 0.050 |
Why?
|
Neurosurgeons | 1 | 2021 | 22 | 0.050 |
Why?
|
Safety | 1 | 2021 | 145 | 0.050 |
Why?
|
Blood Transfusion | 1 | 2022 | 205 | 0.050 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2020 | 9 | 0.050 |
Why?
|
Gasoline | 1 | 2020 | 8 | 0.050 |
Why?
|
Burn Units | 1 | 2020 | 14 | 0.050 |
Why?
|
Body Surface Area | 1 | 2020 | 20 | 0.050 |
Why?
|
Inpatients | 1 | 2022 | 208 | 0.040 |
Why?
|
Pain Management | 1 | 2022 | 186 | 0.040 |
Why?
|
Antidiarrheals | 1 | 2019 | 3 | 0.040 |
Why?
|
Pain, Postoperative | 1 | 2022 | 214 | 0.040 |
Why?
|
Early Medical Intervention | 1 | 2019 | 16 | 0.040 |
Why?
|
Child, Preschool | 2 | 2017 | 3187 | 0.040 |
Why?
|
Databases, Factual | 1 | 2022 | 622 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2019 | 51 | 0.040 |
Why?
|
Time Factors | 2 | 2018 | 4655 | 0.040 |
Why?
|
Pain | 1 | 2022 | 472 | 0.040 |
Why?
|
Dialysis Solutions | 1 | 2017 | 5 | 0.040 |
Why?
|
Enema | 1 | 2017 | 23 | 0.040 |
Why?
|
Laparotomy | 1 | 2017 | 65 | 0.040 |
Why?
|
Therapeutic Irrigation | 1 | 2017 | 63 | 0.040 |
Why?
|
Florida | 1 | 2017 | 221 | 0.040 |
Why?
|
Prognosis | 1 | 2022 | 2093 | 0.040 |
Why?
|
Liver | 1 | 2022 | 1118 | 0.040 |
Why?
|
Body Mass Index | 1 | 2020 | 867 | 0.040 |
Why?
|
Necrosis | 1 | 2017 | 239 | 0.040 |
Why?
|
Societies, Medical | 1 | 2019 | 403 | 0.030 |
Why?
|
Motorcycles | 1 | 2015 | 5 | 0.030 |
Why?
|
Recurrence | 1 | 2017 | 948 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2016 | 652 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 772 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 951 | 0.030 |
Why?
|
Pilot Projects | 1 | 2017 | 1342 | 0.030 |
Why?
|
Child | 1 | 2022 | 6405 | 0.020 |
Why?
|
Infant | 1 | 2017 | 2891 | 0.020 |
Why?
|
Risk Factors | 1 | 2020 | 5731 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2016 | 3259 | 0.020 |
Why?
|